David Shaw’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

David Shaw’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-49,299	Closed	-$168K	–	5808
2022 Q2	$168K	Buy	49,299 +15,275	+45%	+$84.2K	﹤0.01%	4604
2022 Q1	$311K	Buy	+34,024	New	+$517K	﹤0.01%	4634
2021 Q4	–	Sell	-3,670	Closed	-$120K	–	5866
2021 Q3	$120K	Sell	3,670 -2,225	-38%	-$81.5K	﹤0.01%	4689
2021 Q2	$246K	Sell	5,895 -1,611	-21%	-$82.5K	﹤0.01%	4370
2021 Q1	$491K	Sell	7,506 -2,724	-27%	-$190K	﹤0.01%	3514
2020 Q4	$672K	Buy	10,230 +480	+5%	+$31.3K	﹤0.01%	3248
2020 Q3	$529K	Sell	9,750 -2,678	-22%	-$205K	﹤0.01%	3209
2020 Q2	$1.19M	Sell	12,428 -1,772	-12%	-$132K	﹤0.01%	2802
2020 Q1	$728K	Sell	14,200 -16,828	-54%	-$1.76M	﹤0.01%	2980
2019 Q4	$2.55M	Sell	31,028 -622	-2%	-$43.6K	﹤0.01%	2285
2019 Q3	$2.71M	Sell	31,650 -3,193	-9%	-$341K	﹤0.01%	2134
2019 Q2	$4.44M	Buy	34,843 +975	+3%	+$140K	0.01%	1668
2019 Q1	$6.11M	Buy	33,868 +1,712	+5%	+$248K	0.01%	1416
2018 Q4	$3.57M	Sell	32,156 -615	-2%	-$80.1K	﹤0.01%	1734
2018 Q3	$4.42M	Buy	32,771 +21	+0.1%	+$2.9K	0.01%	1653
2018 Q2	$4.52M	Sell	32,750 -132	-0.4%	-$18.2K	0.01%	1617
2018 Q1	$4.54M	Buy	32,882 +142	+0.4%	+$19.3K	0.01%	1473
2017 Q4	$4.03M	Buy	32,740 +335	+1%	+$46K	0.01%	1640
2017 Q3	$4.42M	Sell	32,405 -1,103	-3%	-$167K	0.01%	1468
2017 Q2	$5.88M	Sell	33,508 -59	-0.2%	-$8.39K	0.01%	1227
2017 Q1	$4.03M	Buy	33,567 +305	+0.9%	+$31.7K	0.01%	1424
2016 Q4	$3.24M	Buy	33,262 +892	+3%	+$81.8K	0.01%	1635
2016 Q3	$3.04M	Buy	32,370 +190	+0.6%	+$19K	0.01%	1617
2016 Q2	$3.46M	Sell	32,180 -181	-0.6%	-$21.2K	0.01%	1524
2016 Q1	$3.88M	Buy	32,361 +1,263	+4%	+$133K	0.01%	1435
2015 Q4	$3.7M	Buy	31,098 +3,401	+12%	+$439K	0.01%	1652
2015 Q3	$4.72M	Buy	27,697 +3,938	+17%	+$755K	0.01%	1436
2015 Q2	$4.6M	Buy	23,759 +5,402	+29%	+$1M	0.01%	1533
2015 Q1	$2.72M	Buy	18,357 +1,241	+7%	+$189K	﹤0.01%	1797
2014 Q4	$2.67M	Buy	17,116 +1,673	+11%	+$241K	﹤0.01%	2038
2014 Q3	$2.21M	Buy	15,443 +107	+0.7%	+$15.5K	﹤0.01%	2161
2014 Q2	$2M	Buy	15,336 +1,805	+13%	+$229K	﹤0.01%	2302
2014 Q1	$1.66M	Buy	13,531 +2,212	+20%	+$240K	﹤0.01%	2569
2013 Q4	$1.2M	Buy	11,319 +1,270	+13%	+$123K	﹤0.01%	3007
2013 Q3	$1.13M	Buy	10,049 +1,486	+17%	+$169K	﹤0.01%	2921
2013 Q2	$966K	Buy	+8,563	New	+$1.05M	﹤0.01%	2745

Other funds holding SRGA

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CLG

Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

David Shaw's SRGA Position: Q3 2022 in Review

David Shaw sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2022, closing a stake of 49,299 shares — an estimated $168K sold.

David Shaw first reported a position in SRGA in Q2 2013 and held it in 36 quarters. The position peaked at $6.11M in Q1 2019. 36 funds tracked by Wall St. Rank hold SRGA as of Q3 2022.

David Shaw reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
David Shaw sold 49,299 Surgalign Holdings, Inc. Common Stock shares in Q3 2022, an estimated $168K.
David Shaw first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
David Shaw's Surgalign Holdings, Inc. Common Stock position peaked at $6.11M in Q1 2019.
36 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.